{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360285705165749632.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/jnr.23160"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjnr.23160"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/jnr.23160"}},{"identifier":{"@type":"PMID","@value":"23239187"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"3‐[(2,4‐dimethoxy)benzylidene]‐anabaseine dihydrochloride protects against 6‐hydroxydopamine‐induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title><jats:p>To explore a novel therapy against Parkinson's disease through enhancement of α7 nicotinic acetylcholine receptor (nAChR), we evaluated the neuroprotective effects of 3‐[(2,4‐dimethoxy)benzylidene]‐anabaseine dihydrochloride (DMXBA; GTS‐21), a functionally selective α7 nAChR agonist, in a rat 6‐hydroxydopamine (6‐OHDA)‐induced hemiparkinsonian model. Microinjection of 6‐OHDA into the nigrostriatal pathway of rats destroys dopaminergic neurons selectively. DMXBA dose dependently inhibited methamphetamine‐stimulated rotational behavior and dopaminergic neuronal loss induced by 6‐OHDA. The protective effects were abolished by methyllycaconitine citrate salt hydrate, an α7 nAChR antagonist. Immunohistochemical study confirmed abundant α7 nAChR expression in the cytoplasm of dopaminergic neurons. These results indicate that DMXBA prevented 6‐OHDA‐induced dopaminergic neuronal loss through stimulating α7 nAChR in dopaminergic neurons. Injection of 6‐OHDA elevated immunoreactivities to glial markers such as ionized calcium binding adaptor molecule 1, CD68, and glial fibrillary acidic protein in the substantia nigra pars compacta of rats. In contrast, these immunoreactivities were markedly inhibited by comicroinjection of DMXBA. Microglia also expressed α7 nAChR in both resting and activated states. Hence, we hypothesize that DMXBA simultaneously affects microglia and dopaminergic neurons and that both actions lead to dopaminergic neuroprotection. The findings that DMXBA attenuates 6‐OHDA‐induced dopaminergic neurodegeneration and glial activation in a rat model of Parkinson's disease raisethe possibility that DMXBA could be a novel therapeutic compound to prevent Parkinson's disease development. © 2012 Wiley Periodicals, Inc.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420001326237345664","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"90532929"},{"@type":"NRID","@value":"1000090532929"}],"foaf:name":[{"@value":"Syuuichirou Suzuki"}]},{"@id":"https://cir.nii.ac.jp/crid/1380285705165749633","@type":"Researcher","foaf:name":[{"@value":"Jun Kawamata"}]},{"@id":"https://cir.nii.ac.jp/crid/1380285705165749251","@type":"Researcher","foaf:name":[{"@value":"Takashi Matsushita"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751137528960","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"20464498"},{"@type":"NRID","@value":"1000020464498"},{"@type":"NRID","@value":"9000010421476"},{"@type":"NRID","@value":"9000025121953"},{"@type":"NRID","@value":"9000401994719"},{"@type":"NRID","@value":"9000401793849"},{"@type":"NRID","@value":"9000412365489"},{"@type":"NRID","@value":"9000402004022"},{"@type":"NRID","@value":"9000399361385"},{"@type":"NRID","@value":"9000370745099"},{"@type":"NRID","@value":"9000410628722"},{"@type":"NRID","@value":"9000401803159"},{"@type":"NRID","@value":"9000021355347"},{"@type":"NRID","@value":"9000258060442"},{"@type":"NRID","@value":"9000020075651"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/bakakyoudai"}],"foaf:name":[{"@value":"Akihiro Matsumura"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751154985728","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"80336403"},{"@type":"NRID","@value":"1000080336403"},{"@type":"NRID","@value":"9000001546905"},{"@type":"NRID","@value":"9000412365482"},{"@type":"NRID","@value":"9000406389318"},{"@type":"NRID","@value":"9000410628719"},{"@type":"NRID","@value":"9000021355354"},{"@type":"NRID","@value":"9000415051910"},{"@type":"NRID","@value":"9000258060445"},{"@type":"NRID","@value":"9000020075594"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/hisahara"}],"foaf:name":[{"@value":"Shin Hisahara"}]},{"@id":"https://cir.nii.ac.jp/crid/1380285705165749637","@type":"Researcher","foaf:name":[{"@value":"Kazuyuki Takata"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326233490816","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"60195295"},{"@type":"NRID","@value":"1000060195295"},{"@type":"NRID","@value":"9000020985803"},{"@type":"NRID","@value":"9000241717301"},{"@type":"NRID","@value":"9000019092837"},{"@type":"NRID","@value":"9000021106567"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0186974"}],"foaf:name":[{"@value":"Yoshihisa Kitamura"}]},{"@id":"https://cir.nii.ac.jp/crid/1380285705165750017","@type":"Researcher","foaf:name":[{"@value":"William Kem"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751163684096","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"60235687"},{"@type":"NRID","@value":"1000060235687"},{"@type":"NRID","@value":"9000006560973"},{"@type":"NRID","@value":"9000005223619"},{"@type":"NRID","@value":"9000000710088"},{"@type":"NRID","@value":"9000005783359"},{"@type":"NRID","@value":"9000257980937"},{"@type":"NRID","@value":"9000258060829"},{"@type":"NRID","@value":"9000006294895"},{"@type":"NRID","@value":"9000018645134"},{"@type":"NRID","@value":"9000021176353"},{"@type":"NRID","@value":"9000022854851"},{"@type":"NRID","@value":"9000287286189"},{"@type":"NRID","@value":"9000240025793"},{"@type":"NRID","@value":"9000000772218"},{"@type":"NRID","@value":"9000021329288"},{"@type":"NRID","@value":"9000257904932"},{"@type":"NRID","@value":"9000258716684"},{"@type":"NRID","@value":"9000021924700"},{"@type":"NRID","@value":"9000239229959"},{"@type":"NRID","@value":"9000021260236"},{"@type":"NRID","@value":"9000021355379"},{"@type":"NRID","@value":"9000258060446"},{"@type":"NRID","@value":"9000014570503"},{"@type":"NRID","@value":"9000021360150"},{"@type":"NRID","@value":"9000023373685"},{"@type":"NRID","@value":"9000272998126"},{"@type":"NRID","@value":"9000020075612"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0012356"}],"foaf:name":[{"@value":"Shun Shimohama"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03604012"},{"@type":"EISSN","@value":"10974547"}],"prism:publicationName":[{"@value":"Journal of Neuroscience Research"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2012-12-14","prism:volume":"91","prism:number":"3","prism:startingPage":"462","prism:endingPage":"471"},"reviewed":"false","dc:rights":["http://onlinelibrary.wiley.com/termsAndConditions#vor"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjnr.23160"},{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/jnr.23160"}],"createdAt":"2012-12-14","modifiedAt":"2025-04-23","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=alpha7%20Nicotinic%20Acetylcholine%20Receptor","dc:title":"alpha7 Nicotinic Acetylcholine Receptor"},{"@id":"https://cir.nii.ac.jp/all?q=Pyridines","dc:title":"Pyridines"},{"@id":"https://cir.nii.ac.jp/all?q=Neurodegenerative%20Diseases","dc:title":"Neurodegenerative Diseases"},{"@id":"https://cir.nii.ac.jp/all?q=Parkinson%20Disease","dc:title":"Parkinson Disease"},{"@id":"https://cir.nii.ac.jp/all?q=Receptors,%20Nicotinic","dc:title":"Receptors, Nicotinic"},{"@id":"https://cir.nii.ac.jp/all?q=Benzylidene%20Compounds","dc:title":"Benzylidene Compounds"},{"@id":"https://cir.nii.ac.jp/all?q=Rats","dc:title":"Rats"},{"@id":"https://cir.nii.ac.jp/all?q=Rats,%20Sprague-Dawley","dc:title":"Rats, Sprague-Dawley"},{"@id":"https://cir.nii.ac.jp/all?q=Neuroprotective%20Agents","dc:title":"Neuroprotective Agents"},{"@id":"https://cir.nii.ac.jp/all?q=Animals","dc:title":"Animals"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Nicotinic%20Agonists","dc:title":"Nicotinic Agonists"},{"@id":"https://cir.nii.ac.jp/all?q=Oxidopamine","dc:title":"Oxidopamine"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782112601216","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"22390180"},{"@type":"JGN","@value":"JP22390180"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22390180/"}],"notation":[{"@language":"ja","@value":"神経変性疾患に対する骨髄幹細胞移植による新規治療法開発の基礎研究"},{"@language":"en","@value":"Basic reserach for developing a new therapy by transplantation of mesenchymal stem cells against neurodegenerative diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1040000782176836736","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23659460"},{"@type":"JGN","@value":"JP23659460"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23659460/"}],"notation":[{"@language":"ja","@value":"インビトロ血液脳関門システム構築による虚血性脳細胞傷害の病態解析"},{"@language":"en","@value":"Pathophysiological analysis for the ischemic brain damage using in vitro blood-brain barrier system"}]},{"@id":"https://cir.nii.ac.jp/crid/1040000782257683968","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"25460109"},{"@type":"JGN","@value":"JP25460109"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25460109/"}],"notation":[{"@language":"ja","@value":"酸化ストレスセンサーDJ-1を分子標的とした神経変性疾患治療薬の創製"},{"@language":"en","@value":"Study of oxydative stress sensor DJ-1 for therapeutic target of neurodegenerative diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257153392256","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23659384"},{"@type":"JGN","@value":"JP23659384"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23659384/"}],"notation":[{"@language":"ja","@value":"幹細胞を中心とした細胞供給システムの解明"},{"@language":"en","@value":"Elucidation of cell supply system focusing on stem cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257199420672","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"24659352"},{"@type":"JGN","@value":"JP24659352"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24659352/"}],"notation":[{"@language":"ja","@value":"神経変性疾患モデルにおける神経免疫システムの解析と治療応用の検討"},{"@language":"en","@value":"Analysis and therapeutic application of  the neuroimmune system in the neurodegenerative disease models"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011144227750272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Stimulating Nicotinic Receptors Trigger Multiple Pathways Attenuating Cytotoxicity in Models of Alzheimer's and Parkinson's Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145045543424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360023718183172352","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes."}]},{"@id":"https://cir.nii.ac.jp/crid/1360292618788503808","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Time course of nigrostriatal degeneration in parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619049223040","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Disease model: Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621528604544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nicotine, but neither the α4β2 ligand RJR2403 nor an α7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182344603392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094045698944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094224542976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Characterization of the neuroprotective and toxic effects of α7 nicotinic receptor activation in PC12 cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094555560960","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Co-localization of activating transcription factor 3 and phosphorylated c-Jun in axotomized facial motoneurons"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095182924416","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Glial reactions in Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095944059136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Proteasomal function is impaired in substantia nigra in Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096218975616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prospects for new restorative and neuroprotective treatments in Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096525363968","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Animal models of Parkinson’s disease progression"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657324694528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855568926861440","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569165191680","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569522410112","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,<i>In Vitro,</i>Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571190012032","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044184300032","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518419233152","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518475133952","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518983252096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520090002688","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Progressive activation of adult microglial cells in vitro"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520183078400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994597673984","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Risk and protective factors for Parkinson's disease: A study in Swedish twins"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995293152768","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995621688704","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hydroxy Metabolites of the Alzheimer's Drug Candidate 3-[(2,4-Dimethoxy)Benzylidene]-Anabaseine Dihydrochloride (GTS-21): Their Molecular Properties, Interactions with Brain Nicotinic Receptors, and Brain Penetration"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469213330432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944463737216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cholinergic modulation of microglial activation by α7 nicotinic receptors"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262946216555520","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: Implications for Parkinson's Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418643854848","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418930715776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra11Published on the World Wide Web on 1 December 2000."}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893576081408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895551073536","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A nicotinic agonist (GTS-21), eyeblink classical conditioning and nicotinic receptor binding in rabbit brain"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368261891840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368529053056","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369647124992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nicotinic receptor stimulation protects neurons against β‐amyloid toxicity"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370160841216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Non-Steroidal Anti-Inflammatory Drugs and Brain Inflammation: Effects on Microglial Functions"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107371278339712","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843469124864","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845315012096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tyrosine hydroxylase phosphorylation: regulation and consequences"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318373318400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319541833472","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effects of the α7 Nicotinic Acetylcholine Receptor Agonist Gts-21 on the Innate Immune Response in Humans"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320004888064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320177123328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP<sub>3</sub>pathway and modulate the cell activation toward a neuroprotective role"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320619230336","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793239940352","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793265796480","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793595283072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Safety, Pharmacokinetics, and Effects on Cognitive Function of Multiple Doses of GTS-21 in Healthy, Male Volunteers"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794185970816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951796117575296","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pharmacokinetics and urinary excretion of DMXBA (GTS-21), a compound enhancing cognition"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269181939840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Selective α7 Agonist GTS-21 Attenuates Cytokine Production in Human Whole Blood and Human Monocytes Activated by Ligands for TLR2, TLR3, TLR4, TLR9, and RAGE"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269539406592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone‐induced Parkinson's disease models"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270556525056","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Missing pieces in the Parkinson's disease puzzle"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270777147648","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mechanisms of Neuroprotective Effects of Nicotine and Acetylcholinesterase Inhibitors: Role of α4 and α7 Receptors in Neuroprotection"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270838042368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270984149120","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1370861396359967744","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Toxin‐induced and genetic animal models of Parkinson's disease"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/jnr.23160"},{"@type":"KAKEN","@value":"PRODUCT-13356825"},{"@type":"KAKEN","@value":"PRODUCT-13356845"},{"@type":"KAKEN","@value":"PRODUCT-14283971"},{"@type":"KAKEN","@value":"PRODUCT-15069502"},{"@type":"KAKEN","@value":"PRODUCT-14281356"},{"@type":"KAKEN","@value":"PRODUCT-14281354"},{"@type":"KAKEN","@value":"PRODUCT-14787923"},{"@type":"KAKEN","@value":"PRODUCT-13356837"},{"@type":"OPENAIRE","@value":"doi_dedup___::606190ca2b92a1f958ec4ddfa63e9c4e"},{"@type":"CROSSREF","@value":"10.1016/j.neurobiolaging.2017.10.021_references_DOI_S75j8pVuOjHJ1euKuIPTAmP3Glz"},{"@type":"CROSSREF","@value":"10.1016/j.neuint.2016.02.008_references_DOI_S75j8pVuOjHJ1euKuIPTAmP3Glz"}]}